Gustafsson G - Search Results

1

Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.

Schrøder H, Kjeldahl M, Boesen AM, Nielsen OJ, Schmidt K, Johnsen HE, Gregersen H, Heyman M, Gustafsson G. Schrøder H, et al. Among authors: gustafsson g. Dan Med Bull. 2006 Feb;53(1):76-9. Dan Med Bull. 2006. PMID: 16761337

2

[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].

Schrøder H, Kjeldstad M, Boesen AM, Nielsen OJ, Schmidt KG, Johnsen HE, Gregersen H, Gustafsson G. Schrøder H, et al. Among authors: gustafsson g. Ugeskr Laeger. 2006 Jun 26;168(26-32):2554-8. Ugeskr Laeger. 2006. PMID: 16824410 Danish.

3

The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse.

Schmiegelow K, Heyman M, Gustafsson G, Lausen B, Wesenberg F, Kristinsson J, Vettenranta K, Schroeder H, Forestier E, Rosthoej S; Nordic Society of Paediatric Haematology and Oncology (NOPHO). Schmiegelow K, et al. Among authors: gustafsson g. Leukemia. 2010 Apr;24(4):715-20. doi: 10.1038/leu.2009.303. Epub 2010 Feb 4. Leukemia. 2010. PMID: 20130603 Free article.

4

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol.

Hallböök H, Gustafsson G, Smedmyr B, Söderhäll S, Heyman M; Swedish Adult Acute Lymphocytic Leukemia Group; Swedish Childhood Leukemia Group. Hallböök H, et al. Among authors: gustafsson g. Cancer. 2006 Oct 1;107(7):1551-61. doi: 10.1002/cncr.22189. Cancer. 2006. PMID: 16955505 Free article.

5

Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.

Schmiegelow K, Schrøder H, Gustafsson G, Kristinsson J, Glomstein A, Salmi T, Wranne L. Schmiegelow K, et al. Among authors: gustafsson g. J Clin Oncol. 1995 Feb;13(2):345-51. doi: 10.1200/JCO.1995.13.2.345. J Clin Oncol. 1995. PMID: 7531219

6

Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).

Schroeder H, Garwicz S, Kristinsson J, Siimes MA, Wesenberg F, Gustafsson G. Schroeder H, et al. Among authors: gustafsson g. Med Pediatr Oncol. 1995 Nov;25(5):372-8. doi: 10.1002/mpo.2950250503. Med Pediatr Oncol. 1995. PMID: 7674994

7

Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92.

Calero Moreno TM, Gustafsson G, Garwicz S, Grandér D, Jonmundsson GK, Frost BM, Mäkipernaa A, Rasool O, Savolainen ER, Schmiegelow K, Söderhäll S, Vettenranta K, Wesenberg F, Einhorn S, Heyman M. Calero Moreno TM, et al. Among authors: gustafsson g. Leukemia. 2002 Oct;16(10):2037-45. doi: 10.1038/sj.leu.2402697. Leukemia. 2002. PMID: 12357355

8

Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia.

Schmiegelow K, Björk O, Glomstein A, Gustafsson G, Keiding N, Kristinsson J, Mäkipernaa A, Rosthøj S, Szumlanski C, Sørensen TM, Weinshilboum R. Schmiegelow K, et al. Among authors: gustafsson g. J Clin Oncol. 2003 Apr 1;21(7):1332-9. doi: 10.1200/JCO.2003.04.039. J Clin Oncol. 2003. PMID: 12663723 Clinical Trial.

9

Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries.

Schroeder H, Gustafsson G, Saarinen-Pihkala UM, Glomstein A, Jonmundsson G, Nysom K, Ringdén O, Mellander L. Schroeder H, et al. Among authors: gustafsson g. Bone Marrow Transplant. 1999 Mar;23(6):555-60. doi: 10.1038/sj.bmt.1701617. Bone Marrow Transplant. 1999. PMID: 10217185

10

Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature.

Abildgaard L, Ellebaek E, Gustafsson G, Abrahamsson J, Hovi L, Jonmundsson G, Zeller B, Hasle H. Abildgaard L, et al. Among authors: gustafsson g. Ann Hematol. 2006 May;85(5):275-80. doi: 10.1007/s00277-005-0045-5. Epub 2006 Mar 4. Ann Hematol. 2006. PMID: 16518605 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page